개인구독
소속 기관이 없으신 경우, 개인 정기구독을 하시면 저렴하게
논문을 무제한 열람 이용할 수 있어요.
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 대한외과학회 Annals of Surgical Treatment and Research Annals of Surgical Treatment and Research Vol.99 No.1
- 발행연도
- 2020.7
- 수록면
- 8 - 17 (10page)
이용수
이 논문의 연구 히스토리 (3)
2016
The SUV on 18F-FDG-PET/CT imaging as an independent predictor for overall survival and disease free survival after hepatectomy of HCC (less than 5cm)
Xu-Guang Hu
,
Hee-Jung Wang
,
Bong-Wan Kim
외 1명
한국간담췌외과학회 학술대회지
2016.04
학술대회자료
Transplantation versus hepatectomy for hepatocellular carcinoma less than 2cm
Xu-Guang Hu
,
Hee-Jung Wang
,
Bong-Wan Kim
외 1명
한국간담췌외과학회 학술대회지
2016.04
학술대회자료
- 이 논문의 후속연구가 궁금하신가요?
- 연관 학술논문 또는 학술발표를 통해 보다 발전된 연구결과를 확인하실 수 있습니다.
- 이 논문의 연구 히스토리 확인하기
초록· 키워드
오류제보하기
Purpose: Hepatocellular carcinoma (HCC) patients with major portal vein tumor thrombosis (mPVTT) complications were generally characterized by extremely poor prognoses. The aim of this study was to explore the role of <SUP>18</SUP>F-fluorodeoxyglucose (18F-FDG) PET/CT imaging in predicting HCC complicated by mPVTT.
Methods: Five hundred one HCC patients received surgery in our hospital during November 2008 to December 2014, among which 32 patients (6.4%) were diagnosed as HCC complicated by mPVTT. Six cases were excluded for reasons of complex medical conditions, including 2 cases of salvage liver transplantation, 2 cases of re-resection, 1 case of mPVTT combined with inferior vina cava tumor thrombosis, and 1 case of residual portal vein tumor thrombosis. Ultimately, 26 cases were enrolled in this study. The maximal tumor standardized uptake value (SUVmax) was identified as a predictive factor and detected. The univariate and multivariate regression analyses were performed to identify the prognostic factors for recurrence-free survival (RFS) and overall survival (OS) of HCC patients complicated by mPVTT.
Results: Our results showed that the median OS was 16 months. The 1-, 3-, and 5-year cumulative OS was 55.6%, 31.7%, and 31.7%, respectively. The multivariate regression analysis revealed that SUVmax ≥ 4.65 was the only independent risk factor for RFS and OS.
Conclusion: SUVmax was an independent predictor for RFS and OS of patients suffering from both HCC and mPVTT. L ow SUVmax could serve as an effective factor for selecting candidates with low recurrence risks and for helping with improving patient survival after surgical resection.
Methods: Five hundred one HCC patients received surgery in our hospital during November 2008 to December 2014, among which 32 patients (6.4%) were diagnosed as HCC complicated by mPVTT. Six cases were excluded for reasons of complex medical conditions, including 2 cases of salvage liver transplantation, 2 cases of re-resection, 1 case of mPVTT combined with inferior vina cava tumor thrombosis, and 1 case of residual portal vein tumor thrombosis. Ultimately, 26 cases were enrolled in this study. The maximal tumor standardized uptake value (SUVmax) was identified as a predictive factor and detected. The univariate and multivariate regression analyses were performed to identify the prognostic factors for recurrence-free survival (RFS) and overall survival (OS) of HCC patients complicated by mPVTT.
Results: Our results showed that the median OS was 16 months. The 1-, 3-, and 5-year cumulative OS was 55.6%, 31.7%, and 31.7%, respectively. The multivariate regression analysis revealed that SUVmax ≥ 4.65 was the only independent risk factor for RFS and OS.
Conclusion: SUVmax was an independent predictor for RFS and OS of patients suffering from both HCC and mPVTT. L ow SUVmax could serve as an effective factor for selecting candidates with low recurrence risks and for helping with improving patient survival after surgical resection.
목차
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
참고문헌 (25)
참고문헌 신청
Ikai I / 2003 / Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins / Surg Oncol Clin N Am 12:65~75
Llovet JM / 1999 / Natural history of untreated nonsurgical hepatocellular carcinoma : rationale for the design and evaluation of therapeutic trials / Hepatology 29:62~67
Villa E / 2000 / Natural history of inoperable hepatocellular carcinoma : estrogen receptors' status in the tumor is the strongest prognostic factor for survival / Hepatology 32:233~238
Iwao I / 2010 / Report of the 18th follow-up survey of primary liver cancer in Japan / Hepatol Res 40:1043~1059
Kokudo T / 2016 / Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion / J Hepatol 65:938~943
Llovet JM / 1999 / Natural history of untreated nonsurgical hepatocellular carcinoma : rationale for the design and evaluation of therapeutic trials / Hepatology 29:62~67
Villa E / 2000 / Natural history of inoperable hepatocellular carcinoma : estrogen receptors' status in the tumor is the strongest prognostic factor for survival / Hepatology 32:233~238
Iwao I / 2010 / Report of the 18th follow-up survey of primary liver cancer in Japan / Hepatol Res 40:1043~1059
Kokudo T / 2016 / Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion / J Hepatol 65:938~943
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Is multidisciplinary treatment effective for hepatocellular carcinoma with portal vein tumor thrombus?
Journal of Liver Cancer
2022 .03
-
Upfront liver resection in patients with resectable hepatocellular carcinoma with portal vein tumor thrombus
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Hepatocellular carcinoma with portal vein invasion: Non-surgical treatment
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Down-staging with localized concurrent chemoradiotherapy can identify optimal surgical candidates in hepatocellular carcinoma with portal vein tumor thrombus
한국간담췌외과학회 학술대회지
2016 .04
-
[Hepato-Biliary and Pancreas] Network Meta-analysis to Compare the Efficacy of Different Treatment Regimens in Patients with Hepatocellular Carcinoma Accompanied by Portal Vein Tumor Thrombus
대한외과학회 학술대회 초록집
2022 .05
-
Prognostic value of pretreatment <sup>18</sup>F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
Radiation oncology journal : ROJ
2015 .01
-
Non-systemic non-surgical therapy for hepatocellular carcinoma with portal vein tumor thrombosis
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Laparoscopic right hepatectomy after portal vein embolization in hepatocellular carcinoma
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Hepatocellular carcinoma with atrial tumor thrombus presenting as myxoma: Resection under cardiopulmonary bypass
Annals of Hepato-Biliary-Pancreatic Surgery
2020 .11
-
Direct Thrombus Imaging in Stroke
대한뇌졸중학회지
2016 .01
-
Long-term Survival of a Patient with a Large Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombosis and Spontaneous Tumor Rupture
Journal of Liver Cancer
2020 .01
-
Metastatic papillary renal cell carcinoma with portal vein tumor thrombosis confirmed on blind liver biopsy
Journal of Liver Cancer
2024 .03
-
The clinical management of hepatocellular carcinoma in China: Progress and challenges
Clinical and Molecular Hepatology
2023 .04
-
F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging for Diagnosing Ovarian Small Cell Carcinoma of the Hypercalcemic Type
Nuclear medicine and molecular imaging : NMMI
2016 .01
-
Clinical usefulness of post-operative 18F-fluorodeoxyglucose positron emission tomography-computed tomography in canine hemangiosarcoma
Journal of Veterinary Science
2016 .06
-
The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea
Clinical and Molecular Hepatology
2023 .01
-
Computed Tomography-Based Thrombus Imaging for the Prediction of Recanalization after Reperfusion Therapy in Stroke
대한뇌졸중학회지
2017 .01
-
The response of thrombosis in the portal vein or hepatic vein in hepatocellular carcinoma to radiation therapy
Radiation oncology journal : ROJ
2016 .01
-
How long should physicians follow up with patients after curative treatment for hepatocellular carcinoma?
Clinical and Molecular Hepatology
2020 .01
-
The use of 18F-FDG positron emission tomography to predict tumour recurrence in hepatocellular carcinoma patients after hepatectomy
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
이 논문의 저자 정보
최근 본 자료
댓글(0)
0